Company Cotinga Pharmaceuticals Inc. Toronto S.E.
Equities
COT
CA22675B2021
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.035 CAD | -41.67% |
|
-22.22% | -41.67% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Alison D. Silva
PSD | President | 46 | 31/12/14 |
Debi Sanderson
COO | Chief Operating Officer | - | - |
Chief Tech/Sci/R&D Officer | 61 | 11/06/17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 30/06/18 | |
John C. Drake
CHM | Chairman | - | 19/02/07 |
Alison D. Silva
PSD | President | 46 | 31/12/14 |
David Sanderson
BRD | Director/Board Member | - | 04/12/13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 21,986,415 | 15,211,245 ( 69.18 %) | 0 | 69.18 % |
Company contact information
Cotinga Pharmaceuticals, Inc.
127 Main Street
02129, Boston
+
![address Cotinga Pharmaceuticals Inc.(COT)](https://cdn.zonebourse.com/static/address/37446299.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+19.78% | 126B | |
+24.76% | 118B | |
+24.25% | 27.87B | |
-16.97% | 20.95B | |
-14.83% | 16.92B | |
-13.73% | 16.18B | |
+10.40% | 14.84B | |
-47.10% | 14.79B | |
+53.46% | 14.08B |
- Stock Market
- Equities
- COTQF Stock
- COT Stock
- Company Cotinga Pharmaceuticals Inc.